
Healthpeak Properties PEAK
Quarterly report 2026-Q1
added 05-06-2026
Healthpeak Properties General and Administrative Expenses 2011-2026 | PEAK
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Healthpeak Properties
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90.4 M | 97.2 M | 95.1 M | 131 M | 98.3 M | 93.2 M | 93 M | 96.7 M | 88.8 M | 104 M | 96 M | 82.2 M | 109 M | 79.5 M | 96.2 M | 83 M | 77.9 M | 73.7 M | 67.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 M | 67.5 M | 92.2 M |
Quarterly General and Administrative Expenses Healthpeak Properties
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.6 M | 19.9 M | 20.8 M | 26.1 M | - | 23.2 M | 26.7 M | 23.3 M | - | 23.1 M | 25.9 M | 24.5 M | - | 24.5 M | 24.8 M | 23.8 M | - | 23.3 M | 24.1 M | 24.9 M | - | 21.7 M | 23.7 M | 22.3 M | - | 23 M | 27.1 M | 21.4 M | - | 23.5 M | 22.5 M | 29.2 M | - | 23.5 M | 21.3 M | 22.5 M | - | 34.8 M | 22.8 M | 25.5 M | - | 20.5 M | 28.8 M | 24.8 M | - | 19.5 M | 21.7 M | 20.9 M | - | 45.3 M | 24.1 M | 20.7 M | - | 19.4 M | 14.8 M | 20.1 M | - | 19.6 M | 34.9 M | 22 M | 19.6 M | 20.5 M | 24.9 M | 22.9 M | 20.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 45.3 M | 14.8 M | 23.8 M |
General and Administrative Expenses of other stocks in the Reit healthcare industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Global Medical REIT
GMRE
|
20 M | - | - | $ 2.37 B | ||
|
Sabra Health Care REIT
SBRA
|
53.7 M | $ 20.72 | 0.05 % | $ 5 B | ||
|
National Health Investors
NHI
|
26.9 M | $ 76.42 | -0.17 % | $ 3.58 B | ||
|
The GEO Group
GEO
|
236 M | $ 23.52 | 1.77 % | $ 3.23 B | ||
|
Ventas
VTR
|
177 M | $ 88.18 | 0.2 % | $ 40.1 B | ||
|
LTC Properties
LTC
|
31.1 M | $ 38.48 | -0.34 % | $ 1.78 B | ||
|
Welltower
WELL
|
1.75 B | $ 216.17 | 0.07 % | $ 144 B | ||
|
Omega Healthcare Investors
OHI
|
104 M | $ 47.9 | -0.75 % | $ 14 B |